Was ist gesichert in der Therapie der Sepsis?What is evidence-based in the treatment of sepsis?

[11] Pletz M(2016)Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial JAMA 316 509-430

[12] Gastmeier P(2017)Angiotensin II for the Treatment of Vasodilatory Shock N Engl J Med 377 419-2143

[13] Lemmen SW(2000)Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group Lancet 356 2139-847

[14] Meier-Hellmann A(2018)Mechanical ventilation and extracorporeal membrane oxygena tion in acute respiratory insufficiency Dtsch Arztebl Int 115 840-611

[15] Ferrer R(2015)Short version S2e guidelines: “Positioning therapy and early mobilization for prophylaxis or therapy of pulmonary function disorders” Anaesthesist. 64 596-77

[16] Martin-Loeches I(2017)Noninvasive ventilation of patients with acute respiratory distress syndrome. Insights from the LUNG SAFE study Am J Respir Crit Care Med 195 67-251

[17] Phillips G(2020)Timing of initiation of renal-replacement therapy in acute kidney injury N Engl J Med 383 240-341

[18] Osborn TM(1976)Steroids in the treatment of clinical septic shock Ann Surg 184 333-1234

[19] Townsend S(2015)Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis Intensive Care Med 41 1220-808

[20] Dellinger RP(2018)Adjunctive glucocorticoid therapy in patients with septic shock N Engl J Med 378 797-818

[11] Pletz M(2016)Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial JAMA 316 509-430

[12] Gastmeier P(2017)Angiotensin II for the Treatment of Vasodilatory Shock N Engl J Med 377 419-2143

[13] Lemmen SW(2000)Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group Lancet 356 2139-847

[14] Meier-Hellmann A(2018)Mechanical ventilation and extracorporeal membrane oxygena tion in acute respiratory insufficiency Dtsch Arztebl Int 115 840-611

[15] Ferrer R(2015)Short version S2e guidelines: “Positioning therapy and early mobilization for prophylaxis or therapy of pulmonary function disorders” Anaesthesist. 64 596-77

[16] Martin-Loeches I(2017)Noninvasive ventilation of patients with acute respiratory distress syndrome. Insights from the LUNG SAFE study Am J Respir Crit Care Med 195 67-251

[17] Phillips G(2020)Timing of initiation of renal-replacement therapy in acute kidney injury N Engl J Med 383 240-341

[18] Osborn TM(1976)Steroids in the treatment of clinical septic shock Ann Surg 184 333-1234

[19] Townsend S(2015)Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis Intensive Care Med 41 1220-808

[20] Dellinger RP(2018)Adjunctive glucocorticoid therapy in patients with septic shock N Engl J Med 378 797-818